Hormonal Supplements Global Market Opportunities And Strategies To 2035

Hormonal Supplements Market Definition

Hormonal supplements are pharmaceutical or nutraceutical products designed to support, regulate, or replace hormones in the body when natural hormone levels are insufficient or imbalanced. These supplements may contain synthetic or bioidentical hormones such as estrogen, progesterone, testosterone, thyroid hormones, or precursors that influence hormone production. The primary purpose of hormonal supplements is to restore hormonal balance, alleviate symptoms associated with hormonal deficiencies or disorders and support overall physiological health. The hormonal supplements market consists of sales by entities (organizations, sole traders and partnerships) of products that contain hormones, hormone analogs, or hormone-regulating compounds used to support, restore, or modify the body’s natural hormonal balance. These supplements are designed to address hormonal deficiencies, endocrine disorders, reproductive health conditions and age-related hormonal decline. They include formulations such as tablets, capsules, injections and herbal or nutritional hormone-support products. Hormonal supplements may target hormones such as estrogen, progesterone, testosterone, thyroid hormones and growth hormones, which regulate key physiological processes in the body.

Hormonal Supplements Market Segmentation The hormonal supplements market is segmented by type, by form, by application, by indication, by channel and by price tier.

By Type –
The hormonal supplements market is segmented by type into:

• a) DHEA
• b) Estrogen
• c) Growth Hormone
• d) Melatonin
• e) Progesterone
• f) Testosterone
• g) Other Types

The estrogen market was the largest segment of the hormonal supplements market segmented by type, accounting for 26.8% or $2,658.7 million of the total in 2025. Going forward, the melatonin segment is expected to be the fastest growing segment in the hormonal supplements market segmented by type, at a CAGR of 8.9% during 2025-2030.

By Form –
The hormonal supplements market is segmented by form into:

• a) Oral
• b) Injectable
• c) Topical
• d) Other Forms

The oral market was the largest segment of the hormonal supplements market segmented by form, accounting for 48.6% or $4,810.7 million of the total in 2025. Going forward, the injectable segment is expected to be the fastest growing segment in the hormonal supplements market segmented by form, at a CAGR of 6.8% during 2025-2030.

By Application –
The hormonal supplements market is segmented by application into:

1. a) Anti-Aging
2. b) Fertility Treatment
3. c) Hormone Replacement Therapy
4. d) Pregnancy Support
5. e) Performance Enhancement
6. f) Sleep Aid
7. g) Other Applications

The hormone replacement therapy market was the largest segment of the hormonal supplements market segmented by application, accounting for 31.1% or $3,085.3 million of the total in 2025. Going forward, the sleep aid segment is expected to be the fastest growing segment in the hormonal supplements market segmented by application, at a CAGR of 8.5% during 2025-2030.

By Indication –
The hormonal supplements market is segmented by indication into:

• a) Menopause
• b) Andropause
• c) Sleep
• d) Fertility
• e) Anti-Aging And Longevity
• f) Others

The sleep market was the largest segment of the hormonal supplements market segmented by indication, accounting for 21.6% or $2,136.9 million of the total in 2025. Going forward, the sleep segment is expected to be the fastest growing segment in the hormonal supplements market segmented by indication, at a CAGR of 8.2% during 2025-2030.

By Channel –
The hormonal supplements market is segmented by channel into:

1. a) Pharmacy
2. b) Online
3. c) Clinics
4. d) Health Stores
5. e) Institutional

The pharmacy market was the largest segment of the hormonal supplements market segmented by channel, accounting for 35.2% or $3,489.1 million of the total in 2025. Going forward, the online segment is expected to be the fastest growing segment in the hormonal supplements market segmented by channel, at a CAGR of 9.7% during 2025-2030.

By Price Tier –
The hormonal supplements market is segmented by price tier into:

• a) Economy
• b) Mid
• c) Premium
• d) Personalized

The mid market was the largest segment of the hormonal supplements market segmented by price tier, accounting for 36.5% or $3,611.9 million of the total in 2025. Going forward, the personalized segment is expected to be the fastest growing segment in the hormonal supplements market segmented by price tier, at a CAGR of 9.1% during 2025-2030.

By Geography - The hormonal supplements market is segmented by geography into:

o Asia Pacific
• China
• India
• Japan
• Australia
• Taiwan
• South Korea
o South East Asia
• Indonesia
o North America
• USA
• Canada
o South America
• Brazil
o Western Europe
• France
• Germany
• UK
• Italy
• Spain
o Eastern Europe
• Russia
o Middle East
o Africa

North America was the largest region in the hormonal supplements market, accounting for 36.6% or $3,625.6 million of the total in 2025. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the hormonal supplements market will be Asia Pacific and South America where growth will be at CAGRs of 7.8% and 7.6% respectively. These will be followed by Western Europe and Eastern Europe where the markets are expected to grow at CAGRs of 6.4% and 6.2% respectively.

Hormonal Supplements Market Drivers

The key drivers of the hormonal supplements market include: Growing Demand For Natural And Plant-Based Supplements During the forecast period, the growing demand for natural and plant-based supplements is expected to drive the growth in the hormonal supplements market. Increasing consumer preference for clean-label and plant-derived health products is encouraging the adoption of botanical ingredients such as soy isoflavones, black cohosh, maca root and red clover that support hormonal balance. Many individuals perceive plant-based formulations as safer alternatives to synthetic hormone treatments, especially for managing menopause, PMS and thyroid-related concerns. Growing awareness of side effects associated with conventional drugs further pushes consumers toward natural options. Additionally, the expansion of vegan and organic product lines by supplement manufacturers is widening availability. These factors collectively accelerate the uptake of hormone-supporting nutraceutical formulations. The growing demand for natural and plant-based supplements growth contribution during the forecast period in 2025 is 1.6%.

Hormonal Supplements Market Restraints

The key restraints on the hormonal supplements market include: High Cost Of Advanced Or Personalized Hormone Therapy During the forecast period, high cost of advanced or personalized hormone therapy will restrict the growth of the hormonal supplements market. Personalized hormone-related treatments often involve advanced diagnostics, genetic testing and customized formulations, which significantly increase overall costs. These services frequently require specialized medical consultations and laboratory assessments, making them less affordable for many consumers. Limited insurance coverage or reimbursement for such therapies also discourages adoption. Higher prices restrict accessibility primarily to premium consumer segments. Consequently, cost barriers reduce the number of individuals able to pursue personalized hormone-supporting solutions. Growth affected by the high cost of advanced or personalized hormone therapy during the forecast period in 2025 is -1.1%.

Hormonal Supplements Market Competitive Landscape

Major Competitors are:

Nestlé SA (Nature's Bounty, Garden of Life)

Amway Corp.

Herbalife Nutrition Ltd.

GNC Holdings LLC

Life Extension

Other Competitors Include:

NOW health Group Inc.

Blackmores Limited

Thorne Healthtech Inc.

Hims & Hers Health Inc.

Metagenics Inc.

Otsuka Pharmaceutical

Kobayashi Pharmaceutical

DHC

Asahi Group

Yuhan Corporation

Chong Kun Dang Healthcare (CKDHC)

Korea Ginseng Corp

Laiqa Wellness Private Limited

Girlyveda Private Limited

Miror Therapeutics Private Limited

Aurelle Health

Ovum

Bayer AG

Standard Process Inc.

Natural Factors Inc.

Terry Naturally

Vitabiotics Ltd.

HorminaCare Corp

New Chapter Inc.

Gaia Herbs Inc.

Jarrow Formulas Inc.

DITTO

Health & Her

GlaxoSmithKline plc (GSK)

Perrigo Company plc

Glanbia plc

Sanofi S.A.

Besins Healthcare

Teva Pharmaceutical Industries

Tabuk Pharmaceuticals Manufacturing Company

Jamjoom Pharmaceuticals Company

Hormonal Supplements Market Trends

Major trends shaping the hormonal supplements market include: Biotechnology, Genomics And Precision Medicine Major companies operating in the hormonal supplements market are increasingly leveraging hormone-targeted biotechnology, genomics and precision medicine to develop personalized endocrine support solutions. By integrating biomarker testing, digital health platforms and advanced formulation technologies, companies are offering targeted supplements designed to support hormone balance related to menopause andropause, fertility, metabolism and overall endocrine health. These innovations are enabling more precise and individualized supplementation approaches, improving efficacy while addressing the growing consumer demand for preventive healthcare and personalized wellness solutions. For example, in March 2024, SIRIO Pharma, a Germany-based contract development and manufacturing organization (CDMO), launched its personalised women’s health platform, a portfolio of around 25 ready-to-launch nutraceutical formulations designed to address women’s health needs across life stages at Vitafoods Europe. As part of the platform’s debut, the MenoBalance gummy was introduced by SIRIO Pharma and contains ADM (Archer Daniels Midland Company)’s Novasoy soy isoflavone ingredient, delivered in gummy format for the first time to help support menopausal symptom management. Digitalization, Cloud, Big Data And Cybersecurity Key companies operating in the hormonal supplements market are increasingly leveraging digitalization, cloud computing, big data analytics and advanced cybersecurity to enhance personalized endocrine support solutions. These technologies enable companies to securely collect and analyze large volumes of health data, including hormone levels, lifestyle factors and genetic markers, to design individualized supplementation strategies. By integrating telehealth platforms, digital diagnostics and data-driven insights, companies are improving the accessibility, accuracy and effectiveness of hormone health management while strengthening patient engagement and long-term treatment monitoring. For instance, In September 2025, Joi + Blokes, a US-based company specializing in hormone health and precision longevity care, launched its Smart Supplement program, marketed as one of the first digital platforms to personalize daily supplements based on real‑time symptom data and clinical‑grade biomarker analysis. This offering uses big data analytics, clinical laboratory inputs and algorithmic decision logic to generate custom supplement packs designed to support hormone balance among other health domains like metabolism, sleep, inflammation and longevity. Users can choose pathways including clinician‑reviewed plans based on up to 110 biomarkers, creating highly individualized hormone supplement protocols rather than one‑size‑fits‑all formulations.

Opportunities And Recommendations In The Hormonal Supplements Market

Opportunities – The top opportunities in the hormonal supplements market segmented by type will arise in the melatonin segment, which will gain $1,098.0 million of global annual sales by 2030. The top opportunities in the hormonal supplements market segmented by form will arise in the oral segment, which will gain $1,784.2 million of global annual sales by 2030. The top opportunities in the hormonal supplements market segmented by application will arise in the sleep aid segment, which will gain $1,003.4 million of global annual sales by 2030. The top opportunities in the hormonal supplements market segmented by indication will arise in the sleep segment, which will gain $1,031.6 million of global annual sales by 2030. The top opportunities in the hormonal supplements market segmented by channel will arise in the online segment, which will gain $1,661.8 million of global annual sales by 2030. The top opportunities in the hormonal supplements market segmented by price tier will arise in the mid segment, which will gain $1,212.0 million of global annual sales by 2030. The hormonal supplements market size will gain the most in the USA at $1,052.3 million. Recommendations- To take advantage of the opportunities, The Business Research Company recommends the hormonal supplements companies to focus on menopause-specific hormonal supplement expansion and clinical validation, focus on targeted hormone-related sleep support innovation, focus on integrated women’s hormonal wellness and multi-symptom nutraceutical expansion, focus on stage-specific hormonal wellness supplement expansion, focus on ayurvedic phytopharmaceutical hormonal balance solutions, focus on melatonin driven sleep and stress hormonal supplement expansion, focus on injectable hormonal supplement expansion for clinical grade growth, focus on sleep hormonal supplements for circadian and stress-linked demand, focus on personalized hormonal supplementation for precision-driven growth, expand in emerging markets, focus on omnichannel distribution expansion across digital and clinical retail channels, focus on value based tiered pricing strategy for hormonal supplements, focus on digital first education led promotion for hormonal supplements, focus on trust driven multi channel promotion for hormonal wellness brands, focus on sleep aid driven hormonal supplement expansion and focus on online direct-to-consumer channel expansion for hormonal supplements.